Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments

Karen Pollok, David A. Williams

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A transduction strategy has been developed, using fibronectin (FN)assisted retroviral-mediated gene transfer, based on the observation that hematopoietic stem and progenitor cells bind to specific adhesion domains of fibronectin, via the integrins, very late antigen-4 (VLA-4)α4β1 and very late antigen-5 (VLA-5)α5β1. Retrovirus-mediated transduction on a recombinant FN fragment, FN CH-296, containing binding sites for VLA-4 and VLA-5, separated by type III repeats 12 to 14, makes it possible to efficiently target hematopoietic stem and progenitor cells and T-lymphocytes due to colocalization of target cells and retrovirus particles. These gene therapy strategies are applicable to the potential treatment of a variety of acquired and inherited immune disorders.

Original languageEnglish
Pages (from-to)595-604
Number of pages10
JournalCurrent Opinion in Molecular Therapeutics
Volume1
Issue number5
StatePublished - 1999

Fingerprint

Retroviridae
Hematopoietic Stem Cells
Fibronectins
Integrin alpha4beta1
T-Lymphocytes
Genes
Antigens
Immune System Diseases
Integrins
Genetic Therapy
Binding Sites
Therapeutics

Keywords

  • Colocalization
  • Fibronectin
  • Gene transfer
  • Retrovirus-mediated
  • VLA-4
  • VLA-5

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{2cd972a8022c4a01b5a4883debc244ce,
title = "Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments",
abstract = "A transduction strategy has been developed, using fibronectin (FN)assisted retroviral-mediated gene transfer, based on the observation that hematopoietic stem and progenitor cells bind to specific adhesion domains of fibronectin, via the integrins, very late antigen-4 (VLA-4)α4β1 and very late antigen-5 (VLA-5)α5β1. Retrovirus-mediated transduction on a recombinant FN fragment, FN CH-296, containing binding sites for VLA-4 and VLA-5, separated by type III repeats 12 to 14, makes it possible to efficiently target hematopoietic stem and progenitor cells and T-lymphocytes due to colocalization of target cells and retrovirus particles. These gene therapy strategies are applicable to the potential treatment of a variety of acquired and inherited immune disorders.",
keywords = "Colocalization, Fibronectin, Gene transfer, Retrovirus-mediated, VLA-4, VLA-5",
author = "Karen Pollok and Williams, {David A.}",
year = "1999",
language = "English",
volume = "1",
pages = "595--604",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "5",

}

TY - JOUR

T1 - Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments

AU - Pollok, Karen

AU - Williams, David A.

PY - 1999

Y1 - 1999

N2 - A transduction strategy has been developed, using fibronectin (FN)assisted retroviral-mediated gene transfer, based on the observation that hematopoietic stem and progenitor cells bind to specific adhesion domains of fibronectin, via the integrins, very late antigen-4 (VLA-4)α4β1 and very late antigen-5 (VLA-5)α5β1. Retrovirus-mediated transduction on a recombinant FN fragment, FN CH-296, containing binding sites for VLA-4 and VLA-5, separated by type III repeats 12 to 14, makes it possible to efficiently target hematopoietic stem and progenitor cells and T-lymphocytes due to colocalization of target cells and retrovirus particles. These gene therapy strategies are applicable to the potential treatment of a variety of acquired and inherited immune disorders.

AB - A transduction strategy has been developed, using fibronectin (FN)assisted retroviral-mediated gene transfer, based on the observation that hematopoietic stem and progenitor cells bind to specific adhesion domains of fibronectin, via the integrins, very late antigen-4 (VLA-4)α4β1 and very late antigen-5 (VLA-5)α5β1. Retrovirus-mediated transduction on a recombinant FN fragment, FN CH-296, containing binding sites for VLA-4 and VLA-5, separated by type III repeats 12 to 14, makes it possible to efficiently target hematopoietic stem and progenitor cells and T-lymphocytes due to colocalization of target cells and retrovirus particles. These gene therapy strategies are applicable to the potential treatment of a variety of acquired and inherited immune disorders.

KW - Colocalization

KW - Fibronectin

KW - Gene transfer

KW - Retrovirus-mediated

KW - VLA-4

KW - VLA-5

UR - http://www.scopus.com/inward/record.url?scp=0032692396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032692396&partnerID=8YFLogxK

M3 - Article

C2 - 11249666

AN - SCOPUS:0032692396

VL - 1

SP - 595

EP - 604

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 5

ER -